Recombinant Human Papillomavirus Type 33 L1 Protein
Recombinant Human Papillomavirus Type 33 L1 Protein Uses, Dosage, Side Effects, Food Interaction and all others data.
Recombinant Human Papillomavirus Type 33 L1 Protein is contained in Gardasil is a vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) type 33. The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Type 33 which are produced by separate fermentations in recombinant Saccharomyces cerevisiae and self-assembled into VLPs.
| Trade Name | Recombinant Human Papillomavirus Type 33 L1 Protein |
| Generic | Human papillomavirus type 33 L1 capsid protein antigen |
| Human papillomavirus type 33 L1 capsid protein antigen Other Names | L1 protein, Human papillomavirus type 33 Vaccine, Recombinant human papillomavirus type 33 L1 protein |
| Type | |
| Groups | Approved |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Recombinant Human Papillomavirus Type 33 L1 Protein
